Table III.
EBI3 expression | p35 expression | ||||||
---|---|---|---|---|---|---|---|
Clinicopathological characteristic | Mean ± standard deviation | Mean ± standard deviation | n | t/F-value | P-value | t/F-value | P-value |
Position | 2.863 | 0.0052 | 2.850 | 0.0054a | |||
Cancer | 90 | 8.92±2.52 | 6.47±2.67 | ||||
Adjacent to cancer | 90 | 7.87±2.94 | 5.42±2.98 | ||||
Age, years | 0.357 | 0.305 | 1.031 | 0.722 | |||
<65 | 21 | 9.10±2.36 | 7.57±3.14 | ||||
≥65 | 69 | 8.87±2.58 | 6.09±2.96 | ||||
Gleason score | F=9.644 | 0.0002 | F=9.300 | 0.0002b | |||
≤6 | 29 | 7.38±2.67 | 5.24±3.27 | ||||
7 | 34 | 8.82±1.91 | 6.47±2.21 | ||||
8–10 | 27 | 9.96±2.01 | 7.93±1.96 |
P<0.05
P<0.001. EBI3, Epstein-barr virus-induced gene 3; p35, interleukin-12A.